Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1971 2
1975 3
1976 1
1978 1
1983 1
1993 2
1995 1
1997 2
1998 2
2000 2
2004 1
2006 2
2008 3
2009 1
2010 3
2014 2
2015 8
2016 10
2017 12
2018 11
2019 13
2020 20
2021 7
2022 15
2023 13
2024 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
The Stigma of Personality Disorders.
Sheehan L, Nieweglowski K, Corrigan P. Sheehan L, et al. Curr Psychiatry Rep. 2016 Jan;18(1):11. doi: 10.1007/s11920-015-0654-1. Curr Psychiatry Rep. 2016. PMID: 26780206 Review.
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE; PD MED Collaborative Group. Gray R, et al. JAMA Neurol. 2022 Feb 1;79(2):131-140. doi: 10.1001/jamaneurol.2021.4736. JAMA Neurol. 2022. PMID: 34962574 Free PMC article. Clinical Trial.
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
PD Med Collaborative Group; Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE. PD Med Collaborative Group, et al. Lancet. 2014 Sep 27;384(9949):1196-205. doi: 10.1016/S0140-6736(14)60683-8. Epub 2014 Jun 11. Lancet. 2014. PMID: 24928805 Clinical Trial.
Newborn with a Large Intracranial Mass.
Sheehan L, Bichianu D, Obi O, Mazuru-Witten D. Sheehan L, et al. Neoreviews. 2022 Feb 1;23(2):e136-e140. doi: 10.1542/neo.23-2-e136. Neoreviews. 2022. PMID: 35102387 No abstract available.
COVID Experience.
Sheehan LE. Sheehan LE. J Wound Ostomy Continence Nurs. 2020 Jul/Aug;47(4):311. doi: 10.1097/WON.0000000000000669. J Wound Ostomy Continence Nurs. 2020. PMID: 32433097 Free PMC article. No abstract available.
The Self-Stigma of Suicide Attempt Survivors.
Sheehan L, Oexle N, Dubke R, Wan HT, Corrigan PW. Sheehan L, et al. Arch Suicide Res. 2020 Jan-Mar;24(1):34-47. doi: 10.1080/13811118.2018.1510797. Epub 2018 Dec 1. Arch Suicide Res. 2020. PMID: 30142296
Stigma by Any Other Name.
Sheehan L, Fominaya AW, Bink AB, Kraus DJ, Schmidt A, Corrigan PW. Sheehan L, et al. Psychiatr Serv. 2016 Dec 1;67(12):1373-1375. doi: 10.1176/appi.ps.201500319. Epub 2016 Jul 1. Psychiatr Serv. 2016. PMID: 27364810
Benefits and risks of suicide disclosure.
Sheehan L, Oexle N, Armas SA, Wan HT, Bushman M, Glover L, Lewy SA. Sheehan L, et al. Soc Sci Med. 2019 Feb;223:16-23. doi: 10.1016/j.socscimed.2019.01.023. Epub 2019 Jan 21. Soc Sci Med. 2019. PMID: 30690334
134 results